Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin

被引：328

作者：

Knight, Steven D. ^{[1
]}

Adams, Nicholas D. ^{[1
]}

Burgess, JoeIle L. ^{[1
]}

Chaudhari, Amita M. ^{[1
]}

Darcy, Michael G. ^{[1
]}

Donatelli, Carla A. ^{[1
]}

Luengo, Juan I. ^{[1
]}

Newlander, Ken A. ^{[1
]}

Parrish, Cynthia A. ^{[1
]}

Ridgers, Lance H. ^{[1
]}

Sarpong, Martha A. ^{[1
]}

Schmidt, Stanley J. ^{[1
]}

Van Aller, Glenn S. ^{[1
]}

Carson, Jeffrey D. ^{[1
]}

Diamond, Melody A. ^{[1
]}

Elkins, Patricia A. ^{[1
]}

Gardiner, Christine M. ^{[1
]}

Garver, Eric ^{[1
]}

Gilbert, Seth A. ^{[1
]}

Gontarek, Richard R. ^{[1
]}

Jackson, Jeffrey R. ^{[1
]}

Kershner, Kevin L. ^{[1
]}

Luo, Lusong ^{[1
]}

Raha, Kaushik ^{[1
]}

Sherk, Christian S. ^{[1
]}

Sung, Chiu-Mei ^{[1
]}

Sutton, David ^{[1
]}

Tummino, Peter J. ^{[1
]}

Wegrzyn, Ronald J. ^{[1
]}

Auger, Kurt R. ^{[1
]}

Dhanak, Dashyant ^{[1
]}

机构：

[1] GlaxoSmithKline Inc, Collegeville, PA 19426 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2010年 / 1卷 / 01期

关键词：

GSK2126458; phosphoinositide 3-kinase alpha; mammalian target of rapamycin; PI3K/AKT pathway; CANCER-SPECIFIC MUTATIONS; PHOSPHATIDYLINOSITOL; 3-KINASES; PIK3CA; PHOSPHORYLATION; IDENTIFICATION; P110-ALPHA; PATHWAY; CELL;

D O I：

10.1021/ml900028r

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Phosphomositide 3-kinase alpha (PI3K alpha) is a critical regulator of cell growth and transformation, and its signaling pathway is the most commonly mutated pathway in human cancers The mammalian target of rapamycin (mTOR), a class IV PI3K protein kinase, is also a central regulator of cell growth, and mTOR inhibitors are believed to augment the antiproliferative efficacy of PI3K/AKT pathway inhibition 2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide (GSK2126458, 1) has been identified as a highly potent, orally bioavailable inhibitor of PI3K alpha and mTOR with in vivo activity in both pharrnacodynamic and tumor growth efficacy models Compound 1 is currently being evaluated in human clinical trials for the treatment of cancer.

引用

页码：39 / 43

页数：5

共 50 条

[21] Discovery of CT365, a highly potent inhibitor of PI3K and mTOR, for cancer treatment
Xi, Ning
Wu, Yanjun
Wang, Tingjin
Wang, Heng
Li, Zhiyong
Meng, Qingwei
Li, Jing
Wang, Zhaohe
Zhang, Yingjun
CANCER RESEARCH, 2015, 75
[22] Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases
Vaidhyanathan, Shruthi
Wilken-Resman, Brynna
Ma, Daniel J.
Parrish, Karen E.
Mittapalli, Rajendar K.
Carlson, Brett L.
Sarkaria, Jann N.
Elmquist, William F.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (02): : 251 - 259
[23] The dual PI3K/mTOR inhibitor GSK2126458 is effective for treating solid renal tumours in Tsc2+/- mice through suppression of cell proliferation and induction of apoptosis
Narov, Kalin
Yang, Jian
Samsel, Paulina
Jones, Ashley
Sampson, Julian R.
Shen, Ming Hong
ONCOTARGET, 2017, 8 (35) : 58504 - 58512
[24] Discovery of a novel and potent mutant-selective inhibitor of PI3Kα
Gao, Mingming
Qi, Chao
Li, Zhentian
Fan, Qipeng
Wang, Liyang
Zhou, Fei
You, Lin
Zheng, Hewen
Li, Yu
Wu, Liangxing
Yao, Wenqing
Liu, Phillip C.
CANCER RESEARCH, 2024, 84 (06)
[25] Triazines incorporating (R)-3-methylmorpholine are potent inhibitors of the mammalian target of rapamycin (mTOR) with selectivity over PI3Kα
Richard, David J.
Verheijen, Jeroen C.
Yu, Ker
Zask, Arie
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2654 - 2657
[26] Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer
Sutherlin, Daniel P.
Bao, Linda
Berry, Megan
Castanedo, Georgette
Chuckowree, Irina
Dotson, Jenna
Folks, Adrian
Friedman, Lori
Goldsmith, Richard
Gunzner, Janet
Heffron, Timothy
Lesnick, John
Lewis, Cristina
Mathieu, Simon
Murray, Jeremy
Nonomiya, Jim
Pang, Jodie
Pegg, Niel
Prior, Wei Wei
Rouge, Lionel
Salphati, Laurent
Sampath, Deepak
Tian, Qingping
Tsui, Vickie
Wan, Nan Chi
Wang, Shumei
Wei, BinQing
Wiesmann, Christian
Wu, Ping
Zhu, Bing-Yan
Olivero, Alan
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (21) : 7579 - 7587
[27] Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors
D'Angelo, Noel D.
Kim, Tae-Seong
Andrews, Kristin
Booker, Shon K.
Caenepeel, Sean
Chen, Kui
D'Amico, Derin
Freeman, Dan
Jiang, Jian
Liu, Longbin
McCarter, John D.
Miguel, Tisha San
Mullady, Erin L.
Schrag, Michael
Subramanian, Raju
Tang, Jin
Wahl, Robert C.
Wang, Ling
Whittington, Douglas A.
Wu, Tian
Xi, Ning
Xu, Yang
Yakowec, Peter
Yang, Kevin
Zalameda, Leeanne P.
Zhang, Nancy
Hughes, Paul
Norman, Mark H.
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (06) : 1789 - 1811
[28] WJD008, a Dual Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin Inhibitor, Prevents PI3K Signaling and Inhibits the Proliferation of Transformed Cells with Oncogenic PI3K Mutant
Li, Ting
Wang, Jia
Wang, Xiang
Yang, Na
Chen, Si-meng
Tong, Lin-jiang
Yang, Chun-hao
Meng, Ling-hua
Ding, Jian
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03): : 830 - 838
[29] Discovery of Potent and Selective PI3Kγ Inhibitors
Drew, Samuel L.
Thomas-Tran, Rhiannon
Beatty, Joel W.
Fournier, Jeremy
Lawson, Kenneth, V
Miles, Dillon H.
Mata, Guillaume
Sharif, Ehesan U.
Yan, Xuelei
Mailyan, Artur K.
Ginn, Elaine
Chen, Jie
Wong, Kent
Soni, Divyank
Dhanota, Puja
Chen, Pei-Yu
Shaqfeh, Stefan G.
Meleza, Cesar
Pham, Amber T.
Chen, Ada
Zhao, Xiaoning
Banuelos, Jesus
Jin, Lixia
Schindler, Ulrike
Walters, Matthew J.
Young, Stephen W.
Walker, Nigel P.
Leleti, Manmohan Reddy
Powers, Jay P.
Jeffrey, Jenna L.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 11235 - 11257
[30] Discovery of the potent PI3K/mTOR dual inhibitor PF-04979064
Cheng, Hengmiao
Bagrodia, Shubha
Bailey, Simon
Baxi, Sangita M.
Goulet, Lance
Guo, Lisa
Hoffman, Jacqui
Johnson, Ted O.
Johnson, Ted W.
Li, Chunze
Li, John
Liu, Kevin
Liu, Zhengyu
Marx, Matthew A.
Paderes, Gigi
Sun, Shaoxian
Walls, Marlena
Wells, Peter A.
Yang, Anle
Yin, Min-Jean
Zhu, Jingjiang
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240

← 1 2 3 4 5 →